OmniSYS

OmniSYS

OmniSYS was established as a single-family office associated with the founders of XiFin, a healthcare technology company originally known as OmniSYS. The wealth originates from the development of XiFin's revenue-cycle management platform, which automates billing and workflow for laboratories and hospitals across the United States. The family office invests with a direct ownership posture — its primary asset is XiFin (per XiFin website, 2026), the operating company that processes over 1.5 billion claim lines annually for diagnostics providers. Strategy focuses on healthcare software, specifically revenue-cycle management and workflow automation, serving clients in North America. The firm maintains a concentrated portfolio with XiFin as the core operating business; no direct investments in external startups or private equity funds have been disclosed. Team size and deployment figures are not publicly disclosed. A recent event: in 2024, XiFin launched an automated billing solution for SARS-CoV-2 and respiratory panel testing (per firm press release, March 2024). OmniSYS does not maintain separate philanthropic foundations or family office vehicles in public records. The office is based in Dallas with no additional known locations. What distinguishes OmniSYS is its integrated single-family-office structure: the office owns and manages the operating company XiFin rather than holding a diversified portfolio of passive investments. This ownership model means the family's wealth is tied to the growth of a single healthcare software platform, and the office acts more as an operating-company holding group than a traditional allocator of capital across multiple managers or asset classes.